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Decision-making is a complex cognitive process that is impaired in a number of 
psychiatric disorders.  In the laboratory, decision-making is frequently assessed using 
―gambling‖ tasks that are designed to simulate real-life decisions in terms of uncertainty, 
reward and punishment.  Here, we investigate whether lesions of the medial prefrontal 
cortex (PFC) cause impairments in decision-making using a rodent gambling task (rGT).  
In this task, rats have to decide between 1 of 4 possible options: 2 options are 
considered ―advantageous‖ and lead to greater net rewards (food pellets) than the other 
2 ―disadvantageous‖ options.  Once rats attained stable levels of performance on the 
rGT they underwent sham or excitoxic lesions and were allowed to recover for 1 week.  
Following recovery, rats were retrained for 5 days and then the effects of a dopamine 
D1-like receptor antagonist (SCH23390) or a D2-like receptor antagonist (haloperidol) 
on performance were assessed.  Lesioned rats exhibited impaired decision-making: 
they made fewer advantageous choices and chose the most optimal choice less 
frequently than did sham-operated rats.  Administration of SCH23390 (0.03 mg/kg), but 
not haloperidol (0.015-0.03 mg/kg) attenuated the lesion-induced decision-making 
deficit.  These results indicate that the medial PFC is important for decision-making and 
that excessive signaling at D1 receptors may contribute to decision-making 
impairments.   
 
 






































































1. Lesions of the medial prefrontal cortex impaired stable decision-making 
2. The D1 receptor antagonist SCH23390 reversed the lesion-induced decision-making 
deficit. 









































































Decision-making is a complex cognitive process that involves assessing the risk, 
reward, and costs associated with different alternatives and then selecting that which 
will likely lead to the maximal benefit for the individual [1].  Decision-making deficits are 
commonly observed in a number of psychiatric conditions including attention-deficit 
hyperactivity disorder (ADHD; [2]), substance abuse [3], Parkinson‘s Disease [4,5,6], 
problem gambling [7,8] and schizophrenia [9, 10, 11,12].  These decision-making 
deficits can have devastating consequences and may contribute to the poor outcomes 
for afflicted individuals.  Understanding the neural basis of optimal decision-making may 
allow us to develop strategies to treat decision-making impairments.    
 
In the laboratory, decision-making is frequently tested using ―gambling‖ tasks that are 
designed to simulate real-life decisions in terms of uncertainty, reward and punishment 
[1].  The Iowa Gambling Task (IGT; [13]), a task commonly used to assess decision-
making in the laboratory, requires human subjects to choose between 4 different decks 
of cards.  Unbeknownst to the subject, two of the decks of cards are associated with 
large financial gains, and unpredictable even larger losses such that continued choice of 
these decks leads to a net financial loss.  The other two decks are associated with small 
financial gains, and unpredictable smaller losses such that continued choice of these 
decks leads to a net financial gain.  Healthy control subjects develop a preference for 
the advantageous small win/small loss decks, while individuals with ventromedial PFC 
[13] or dorsolateral PFC [14] lesions fail to develop these preferences; instead they 
prefer the disadvantageous large reward/large loss decks. 
 
Recently, rodent ―gambling‖ tasks have been developed that share many of the features 
of the human gambling tasks including uncertainty, reward and punishment [15, 16].  
The rodent gambling task (rGT) developed by Winstanley and colleagues [15,17] is 
notably similar to the IGT— there are 4 response options each of which is associated 
with a different reward/punishment contingency.  Two of the response options are 
associated with small rewards (food pellets) and small, infrequent punishments 



































































with large rewards and large, frequent punishments.  These response contingencies 
result in two options being relatively more ―advantageous‖ than the other two 
―disadvantageous‖ options.  Similar to healthy humans subjects, control rats develop a 
preference for the advantageous small reward/small punishment options over the 
disadvantageous large reward/large punishment options [15]. 
 
Using the rGT developed by Winstanley and colleagues [15, 17], we aimed to determine 
whether lesions of the medial PFC negatively affected stable choice behavior.  It has 
previously been observed that medial PFC and orbitofrontal cortex (OFC) lesions impair 
the development of an advantageous decision-making strategy in rats  [17,18].  Once a 
stable strategy had been established however, OFC lesions did not affect choice 
behavior [17].  Given the role of the medial PFC in human decision-making [14] and 
because a number of psychiatric conditions display pathology in this brain area (e.g., [2-
12] we aimed to determine whether medial PFC lesions would cause a change in rats‘ 
decision-making.  Because ―risk‖ based decision-making is modulated by dopamine [1, 
15, 19] and because medial PFC lesions can cause changes in striatal dopamine 
transmission [20, 21, 22], we also investigated whether D1-like or D2-like receptor 
antagonist administration affected choice behavior in rats with sham or medial PFC 
lesions.  
 
2.0 Materials and Methods 
2.1 Rats 
Twenty-seven male Sprague-Dawley rats born at Oberlin College were used.  Rats 
were maintained on a 14-h/10-h light-dark cycle (lights on at 0700h) and were group 
housed until post-natal day (PND) 55; during this time they had unlimited access to food 
(Purina Rat Chow) and water.  On PND 55 rats were pair housed until the time of 
surgery at which time they were housed singly.  Upon pair housing and throughout the 
experiment rats were food restricted to ~85% of their free feeding weight; rats were fed 
after daily training sessions.  Experiments were conducted in accordance with the Guide 





































































Ibotenic acid and haloperidol were purchased from Sigma-Aldrich (St. Louis, MO).  
Ibotenic acid was dissolved in physiological saline (0.9%) to a final concentration of 10 
g/l.  Haloperidol was dissolved in 75% dimethyl sulfoxide to concentrations of 0.015 
mg/ml and 0.03 mg/ml.  SCH23390 was purchased from Tocris (Ellisville, MO) and was 
dissolved in saline (pH 6.5) to final concentrations of 0.03 mg/ml and 0.06 mg/ml. 
 
2.3 Surgery 
Rats were anesthetized with sodium pentobarbital (65 mg/kg, IP). The skull was 
exposed and burr holes drilled above the medial PFC.  Rats received bilateral injections 
of either saline (n=9) or ibotenic acid (n=12) at the following coordinates (mm relative to 
bregma): AP + 2.8, ML =±0.75, DV –3.3 and DV –2.3 [24].  Rats received two bilateral 
infusions, one at each DV coordinate.  Each infusion delivered 0.4 l/side of 10 g/l 
ibotenic acid at a rate of 0.2 l/min.  The infuser remained in place for an additional 2 
min following each infusion and then was raised for the second infusion or removed.  
Once the infuser was removed, the scalp was sutured shut.     
 
2.4 Rodent Gambling Task (rGT) 
The rGT was based upon that developed by Winstanely and colleagues [15, 17].  Rats 
were trained and tested in 5-hole operant chambers enclosed in sound attenuating 
chambers (Med Associates, Vermont); the center hole was occluded throughout all 
experiments.   
 
Rats were first trained to retrieve food pellets (45-mg, Bio-Serv, Frenchtown NJ) from 
the food magazine over two consecutive days; during these sessions all holes were 
occluded.  Next, rats were trained to nose poke in the holes under a continuous 
reinforcement schedule.  In order to encourage equal nose poking in all 4 holes the two 
outer holes were occluded on the first session and the two inner holes occluded on the 
second session.  On the third session and all subsequent sessions all 4 holes were 
open.  The continuous reinforcement task began with the delivery of 1 food pellet and 



































































extinguished the magazine light and initiated a 5-sec inter-trial interval (ITI).  At the end 
of the ITI, lights at the rear of the holes (aperture lights) were illuminated and rats 
had 10 sec to make a response in any hole.  Responses resulted in the delivery of 
a food pellet reward (Bio-Serv).  Rats were trained on the continuous reinforcement 
task until they received 100 rewards with less than 20 omissions in ~30 min.  
 
Once rats reached criterion performance on the continuous reinforcement task they 
underwent 4 days of forced choice training on the full rGT.  In each forced choice 
session only a single hole was available; this measure ensured that rats had experience 
with the contingencies associated with each hole prior to allowing rats to choose freely 
(see below).  For the full rGT, sessions began with the delivery of a single food pellet 
and illumination of the houselight and the magazine light.  Pellet retrieval extinguished 
the magazine light and initiated a 5-sec ITI.  At the end of the ITI the 4 aperture lights 
were illuminated and rats had 10 sec (limited hold) to make a response in any hole.  A 
response resulted in the assigned outcome (reward/punishment) for that hole (see 
Table 1 for example).  On rewarded trials the aperture lights were all extinguished, the 
magazine light was illuminated and the appropriate number of pellets was delivered to 
the magazine.  On punished trials no pellets were delivered and the houselight and all 
aperture lights, except the one from the chosen hole, were extinguished for the duration 
of the punishment period (i.e., the chosen hole remained illuminated throughout the 
punishment period).  The next trial commenced at the end of the punishment period or 
once the rat retrieved the food pellet reward.  Failing to respond within the limited hold 
was scored as an omission and responses occurring during the ITI were scored as 
premature responses.  Omissions and premature responses were punished with a 5-
sec time out during which the houselight, magazine light and all aperture lights were 
extinguished.  Each session lasted for a total of 60 min.  
 
Four different spatial arrangements of the outcomes across holes were used.  An 
individual rat however, was only trained and tested on a single spatial arrangement of 
outcomes.  Two of the holes had relatively ―advantageous‖ outcomes (increased total 



































































short duration (5-10 sec) of punishment periods (see Table 1).  The advantageous 
choices were associated with smaller rewards (1-2 pellets).  Two holes were associated 
with relatively ―disadvantageous‖ outcomes due to the high probability (0.5-0.6) and 
long duration (30-40 sec) of punishment.  The disadvantageous choices were 
associated with larger rewards (3-4 pellets).  The % responses at each hole and % 
advantageous responses ((# advantageous responses/total responses) * 100) were 
used as indicators of decision-making.  Once % advantageous responding stabilized (< 
5% variability across days), rats underwent surgery and were allowed to recover for 5-7 
days prior to beginning testing. 
 
2.5 Testing 
2.5.1 Effects of medial PFC Lesions on choice behavior 
After a 5-7 day recovery period rats were retested on the rGT for 5 consecutive days in 
order to assess the effects of medial PFC lesions on decision-making.   
 
2.5.2 Effects of SCH23390 on choice behavior 
Next, the ability of the D1-like receptor antagonist SCH23390 to affect decision-making 
behavior in sham-operated and lesioned rats was assessed.  SCH23390 (0.0, 0.03 and 
0.06 mg/kg, IP) was administered 30 min prior to testing; doses were administered in a 
counterbalanced fashion.  Rats were given at least 2 drug-free days between 
consecutive drug doses. 
 
2.5.3 Effects of haloperidol on choice behavior 
Finally, the ability of the D2-like receptor antagonist haloperidol to affect decision-
making behavior in sham-operated and lesion rats was assessed.  Haloperidol (0.0, 
0.015 and 0.03 mg/kg, SC) was administered 30 min prior to testing; doses were 
administered in a counterbalanced fashion.  Rats were given at least 2 drug-free days 





































































Following the last test session rats were anesthetized with sodium pentobarbital (100 
mg/kg, IP) and transcardially perfused with 0.9% NaCl followed by 4% 
paraformaldehyde.  Following perfusions, brains were removed, post-fixed for 24 h and 
then cryoprotected in 30% sucrose prior to slicing on a microtome.  Sections (40 m) 
were mounted on slides, stained with cresyl violet and the extent of the lesion assessed. 
 
2.7 Statistical Analyses 
rGT data were analyzed using repeated measures ANOVAs with Day, Dose and/or % 
Choice per hole as the within-subjects factor and Condition (sham-operated, lesioned) 
as the between-subjects factor.  Significant effects were further analyzed using an 
estimated marginal means procedure with a Bonferroni correction. 
 
Measures of interest included: % advantageous responses, % choice per hole ((# 
responses per hole/ total responses)*100), % omissions ((# omissions/total 





Figure 1 depicts the extent of the medial PFC lesions.  Six rats were excluded from the 
experiment because their choice behavior never reached the pre-surgery stability 
criterion.  One lesioned rat was excluded because of a unilateral lesion and two 
lesioned rats were excluded because of excessive damage that included an 
enlargement of the lateral ventricles.   Thus, 9 rats remained in each group for the 
statistical analyses.  One additional sham-operated rat was excluded from the statistical 
analysis on the haloperidol data because his behavior became unstable following 
SCH23390 administration.  
 
3.2 Post-Lesion Tests 
The % advantageous responses differed across day of test (F(5, 80) = 2.36, P < 0.05; 



































































and lesioned rats (F(1, 16) = 4.00, P = 0.06).  Importantly there was a significant day X 
condition interaction (F(5, 80) = 3.15, P < 0.05).  Post-hoc analysis on the interaction 
revealed that lesioned rats had lower % advantageous responses on day 4 following 
surgery (P < 0.05) and tended to have lower % advantageous responses on day 5 
following surgery (P = 0.07) relative to their pre-surgery baseline performance.  In 
addition, lesioned rats had lower % advantageous responses on post-lesion day 1 (P = 
0.07), post-lesion day 4 (P < 0.05) and post-lesion day 5 (P = 0.05) compared to sham-
operated rats.   
 
When the % choice of each hole were analyzed there was a significant effect of hole 
(F(3, 48)= 181.25, P < 0.01; see Figure  2B) and a significant hole X day interaction 
(F(15, 240) = 1.89, P < 0.05).  On all days, rats chose hole 2 more frequently than they 
chose all other holes (all P < 0.05); an effect that did not differ across days (all P > 
0.05).  Furthermore, there was a trend for a three-way condition X hole X day interaction 
(F(15,240) = 1.67, P = 0.06). Post-hoc analyses revealed that lesioned rats chose hole 
3 more frequently than sham-operated rats on post-lesion days 1, 4 and 5 (all P  0.05) 
and lesioned rats chose hole 1 less frequently than sham-operated rats on post-lesion 
day 3 (P = 0.05).  All other main effects and interactions were not significant (all F < 
1.56, all P > 0.05). 
 
Day of testing significantly affected % omissions (F(5, 80) = 3.86, P < 0.01; see Figure 
2C).  Post-hoc analyses did not reveal that the % omissions were different between any 
two days (all P > 0.05).  There was no effect of condition or a condition X day interaction 
(both F < 1.17, both P > 0.05). 
 
There were no significant effects or interactions for % premature responses (all F < 
1.06, P > 0.05; see Figure 2D). 
 
There was a significant effect of day for the number of magazine entries (F(5, 80) = 



































































given day did not differ from those made on any other day (all P > 0.05).  There was no 
effect of condition nor a condition X day interaction (both F < 0.05, both P > 0.05). 
 
3.3 Effects of SCH23390 administration on decision-making 
Following SCH23390 administration there was a main effect of condition (F(1,16) = 
4.32, P=0.05; see Figure 3A) whereby sham-operated rats had higher % advantageous 
responses than lesion rats.  In addition, there was a significant SCH23390 X condition 
interaction (F(2,32) = 3.57, P < 0.05). Post-hoc analysis on the interaction revealed that 
lesioned-operated rats made fewer advantageous responses than did sham-operated 
rats after 0.0 mg/kg SCH23390 (P < 0.05), but not after either 0.03 or 0.06 mg/kg 
SCH23390 (both P > 0.05).  In addition, lesioned rats made more advantageous 
responses following 0.03 mg/kg than they did following 0.0 mg/kg SCH23390 (P < 0.05).  
There was no effect of SCH23390 on sham-operated rats (F(2,32) = 0.63, P > 0.05). 
 
When the % choice of each hole were analyzed there was a significant main effect of 
hole (F(3,48) = 131.48, P < 0.01; see Figure 3B) and a significant condition X hole 
interaction (F(3,48) = 3.28, P < 0.05).  Sham-operated rats chose hole 2 more 
frequently and tended to choose hole 3 less frequently than lesioned rats (P < 0.05 and 
P = 0.07, respectively).  Both groups responded more in hole 2 than they did in any 
other hole (both P < 0.05).  SCH23390 did not affect % choice of each hole nor were 
there any drug by condition interactions (all F < 1.76, all P > 0.05).  
 
SCH23390 administration dose-dependently affected % omissions (F(2, 32) = 17.34, P 
< 0.01; see Figure 3C).  In addition there was a main effect of condition (F(1, 16) = 
7.69, P < 0.05) and a condition X dose interaction (F(2, 32) = 3.37, P < 0.05).  
Regardless of dose, lesioned rats omitted more trials after SCH23390 administration 
than after vehicle administration (both P < 0.05).  In addition, lesioned rats omitted more 
trials than sham-operated rats after both 0.03 and 0.06 mg/kg SCH23390 administration 
(both P < 0.05).  Importantly, SCH23390 did not affect the % omissions in sham-




































































SCH23390 administration significantly affected % premature responses (F(2,32) = 8.13, 
P < 0.01; see Figure 3D).  In addition, there was a trend for SCH23390 administration 
to affect premature responding differently in sham-operated and lesioned rats (F(2,32) = 
3.02, P = 0.06).  Regardless of condition, rats made fewer premature responses after 
either 0.03 mg/kg or 0.06 mg/kg SCH23390 than they did after 0.0 mg/kg SCH23390 
(both P < 0.05).  Analysis of the dose X condition interaction revealed that the effect of 
dose was primarily due to the effect of SCH23390 administration in lesioned rats.  
Lesioned rats made fewer premature responses following 0.06 mg/kg than they did 
following 0.0 mg/kg SCH23390.  Moreover, following administration of 0.06 mg/kg 
SCH23390 lesion rats made fewer premature responses than did sham-operated rats.  
There was no effect of condition on the % premature responses made (F(1,16) = 2.23, 
P > 0.05). 
  
SCH23390 administration significantly affected the number of magazine entries made 
(F(2,32) = 5.73, P < 0.01; see Figure 3E).  Rats made fewer magazine entries after 
0.06 mg/kg SCH23390 than they did after 0.0 mg/kg SCH23390 (P < 0.05).  There was 
no effect of condition nor was there a condition X dose interaction (both F < 2.51, both P 
> 0.05).  
 
3.4 Effects of haloperidol administration on decision-making 
Following haloperidol administration lesioned rats made fewer advantageous responses 
than did sham-operated rats (F(1,15) = 7.33, P < 0.05; see Figure 4A), but the % 
advantageous responses was not affected by the dose of haloperidol nor was there a 
condition X dose interaction (both F < 1.0, both P > 0.05).  
 
When the % choice of each hole were analyzed there was a significant % choice X 
condition interaction (F(3,45) = 6.27, P < 0.01; see Figure 4B).  Lesioned rats chose 
hole 2 less frequently and hole 3 more frequently than sham-operated rats (both P < 
0.05).   Both groups chose hole 2 more than all other options (all P < 0.01).  Haloperidol 





































































The % omissions committed were not affected by either haloperidol dose or condition 
(all F < 2.48, P > 0.05; see Figure 4C).  
 
Haloperidol significantly affected the % premature responses committed (F(2,30) = 6.21, 
P < 0.01; see Figure 4D); rats made more premature responses following 0.03 mg/kg 
than they did following 0.0 mg/kg haloperidol (P < 0.05).  There was no effect of 
condition nor was there a condition X dose interaction (both F < 1.20, both P > 0.05).  
 
Haloperidol significantly affected the number of magazine entries made (F(2,30) = 3.70, 
P < 0.05; see Figure 4E); however there were no significant differences between doses 
(all P > 0.05).  In addition, there was a trend for lesioned animals to make more 
magazine entries than sham-operated rats (F(1,15) = 3.99, P = 0.06).  There was 
however no condition X dose interaction (F(2, 30)= 1.27, P > 0.05).  
 
4.0 Discussion 
The current experiment investigated the effects of medial PFC lesions on decision-
making behavior in the rGT in well-trained rats.  After receiving a lesion of the medial 
PFC, rats gradually shifted their choices from the most advantageous options to the 
disadvantageous options.  Moreover, optimal decision-making was restored by 
administration of the D1-like receptor antagonist SCH23390, but not by administration of 
the D2-like receptor antagonist haloperidol.  Neither SCH23390 nor haloperidol, at the 
doses used in the current experiment, affected decision-making when administered to 
sham-operated control rats. 
 
4.1 Decision-making on the rodent gambling task 
Rodent gambling tasks, like their human counterparts such as the IGT, require rats 
develop an optimal decision-making strategy based upon the expected reward value of 
each choice option.  In the rGT the expected value of the reward can be determined by 
weighing the probability of attaining reward in any particular trial against the magnitude 



































































in the maximum number of rewards over the entire session, rather than the option that 
results in the maximum number of rewards in any particular trial.  By this definition, the 
optimal choice in our version of the rGT is hole 2; exclusive choice of holes 1, 3 and 4 
result in fewer cumulative pellets over the course of the session compared to exclusive 
choice of hole 2 (see [15]).  ―Advantageous‖ decision-making is defined as responding 
in either of the two holes that lead to the greatest cumulative rewards (i.e., holes 1 and 
2) over the session.  Due to the relatively short duration and relatively low probability of 
punishment, the choice of options that result in the smallest rewards on any given trial 
lead to the greatest net reward over the entire session.  Importantly, rats used in the 
current experiment were able to develop stable optimal decision-making strategies: they 
chose hole 2 more than the other three holes and displayed more advantageous 
responses than disadvantageous responses.  
 
4.2 Effects of medial PFC lesions on decision-making 
We found that large lesions of the medial PFC, which included both the ventral 
(infralimbic) and dorsal (prelimbic) portions, impaired stable decision-making in the rGT.  
Rats with medial PFC lesions chose the advantageous options (holes 1 and 2) less 
frequently than they did prior to surgery and less frequently than did sham-operated 
control rats.  Initially the decrease in advantageous responding was caused by lesioned 
animals increasing their choice of hole 3 (a disadvantageous response); in later testing 
lesioned rats also decreased their choice of hole 2 (an advantageous response).  
Combined, this strategy results in fewer rewards being obtained over the course of the 
session. These data add to a growing body of evidence finding impaired decision-
making following damage to the medial PFC. Indeed, either excitotoxic lesions or 
temporary inactivation of the medial PFC impairs the acquisition of an optimal decision-
making strategy [18, 25].  To date, it is unclear whether the impairment in decision-
making resulted primarily from damage to the prelimbic or infralimbic cortex.  
Although the damage to the prelimbic cortex has been found to impair decision-
making [18, 25], it is not clear whether damage to the ventral portions of the 
medial PFC (i.e., infralimbic cortex) affect decision-making [17, 18].  Nevertheless, 



































































dorsolateral prefrontal cortex, analogous to the rodent medial PFC, perform sub-
optimally on the IGT [14].   
 
The lesion-induced change in decision-making occurred gradually over the course of 
several days suggesting that the change in decision-making was not simply due to a 
failure to remember the contingencies associated with each response hole.  Prior to 
surgery, rats chose the advantageous options on approximately 90% of the trials. 
Following surgery, lesioned rats gradually sampled more from the disadvantageous 
options.  Increased choice of the disadvantageous responses may have occurred either 
because lesioned rats were more sensitive to the size of the reward or because they 
were less sensitive to the punishment (i.e., they were more ―risky‖) associated with 
these options.  To our knowledge there is no evidence that rats with medial PFC lesions 
exhibit an enhanced preference for large rewards over small rewards relative to sham-
operated rats.  Rather, in a delayed reinforcement task, rats with medial PFC lesions 
exhibited a reduced preference for large rewards when the delay to the large reward 
was 0 sec compared to sham-operated control rats [26].  Similarly, in a sustained 
response task, rats with medial PFC lesions exhibited a reduced preference for large 
rewards compared to sham-operated control rats [27].  Both of these results suggest 
that medial PFC lesions may actually cause a preference for small rewards over large 
rewards, a result opposite of that observed in the current experiment.  Furthermore, 
reduced preference for large rewards in the lesioned rats cannot be explained by an 
inability to distinguish between reward magnitudes [28].   Combined, these data indicate 
that an enhanced sensitivity or motivation to obtain the large reward is unlikely to 
explain the shift in decision-making strategy observed following medial PFC lesions.  
 
Alternatively, rats may have increased responding for the disadvantageous options 
(options 3 and 4) because they were less sensitive to the negative consequences 
associated with these options, namely the increased risk of obtaining no reward at all.   
There is limited evidence that rats in which the medial PFC had been temporarily 
inactivated or lesioned exhibit enhanced risk taking behavior [28, 29], in some, but not 



































































to the probabilistic nature of the reward may have contributed to the shift in decision-
making strategy observed by rats with medial PFC lesions.   That is, lesioned rats may 
not have been as sensitive to the duration and/or frequency of the punishment, and thus 
may have chosen the larger reward on more trials.  
 
4.3 Ability of Dopamine Receptor Antagonists to Attenuate Decision-Making 
Deficits 
Large medial PFC lesions (including both prelimbic and infralimbic cortex) can 
affect dopamine signaling, particularly in the striatum. Indeed there is evidence of 
increased DA release [20, but see 30], increased D2 receptor expression [21] and 
increased D1 receptor sensitivity [22] in the striatum following either ablative or 
excitotoxic lesions of the medial PFC.   Moreover, both the prelimbic cortex and 
infralimbic cortex project to the ventral tegmental area [31].  Thus, we sought to 
determine if administration of either a D1-like receptor antagonist, SCH23390, or a D2-
like receptor antagonist, haloperidol, could attenuate the decision-making deficit 
observed following medial PFC lesions.   
 
4.3.1 Effects of SCH23390 administration on decision-making 
Enhanced D1 receptor sensitivity likely contributed to the decision-making deficit 
observed following medial PFC lesions.  Consistent with a previous report [15], D1 
receptor antagonism did not affect decision-making in sham-operated control rats.  In 
contrast, D1 receptor antagonism significantly improved decision-making in lesioned 
rats.  Following administration of SCH23390 the % advantageous choices made by 
lesioned rats was not significantly different from sham-operated controls rats.  In 
addition, the low dose of SCH23390 significantly increased the % advantageous 
responses lesioned rats made relative to administration of vehicle; SCH23390 did not 
affect % advantageous responses in sham-operated rats.  Surprisingly however, 
SCH23390 administration did not significantly increase lesioned rats‘ choice of the most 
optimal hole (hole 2).  Instead the increase in % advantageous responses appears to 
result from small, but not significant, decreases in the choice of the least optimal holes 



































































This may suggest that administration of SCH23390 increased advantageous decision-
making by causing lesioned rats to be more risk averse.  Consistent with this hypothesis 
SCH23390 administration caused rats to be risk averse in a probabilistic reinforcement 
task [32]. 
 
Other rGT performance measures also suggest that lesioned rats exhibited enhanced 
D1 receptor number or sensitivity relative to sham-operated rats.  While sham-operated 
rats treated with SCH23390 exhibited slightly increased omissions and decreased 
premature responses, these effects were potentiated in the lesioned rats.  Combined 
this pattern of performance deficits suggests that lesioned rats were also more 
sensitive to the locomotor impairing effects of D1 receptor antagonism [33] 
thereby providing additional evidence that D1 receptors signaling was enhanced 
following the lesion [22].  Because responding in each of the apertures requires 
the same motor response, it is unlikely that the SCH23390-induced motor deficit 
contributed to the improvement in decision-making.  That is, lesioned rats likely 
exhibited improved decision-making following SCH23390 administration despite 
displaying impaired locomotion. 
 
4.3.2 Effects of haloperidol administration on decision-making 
The results from the current experiment suggest that upregulation of D2-like 
receptor signaling does not contribute to the decision-making impairment 
observed following medial PFC lesions.  Not only did the D2-like receptor 
antagonist haloperidol fail to affect decision-making in both sham-operated and 
lesioned rats, there was no evidence that it differentially affected any 
performance measure in the two groups.  Indeed, the only measure affected by 
haloperidol administration was premature responses; this measure was affected 
equally in both groups.  It is possible that we did not use a high enough dose of 
haloperidol to observe a change in decision-making; problematically, higher 
doses of haloperidol are known to cause performance deficits in an attention task 
[34] and induced catalepsy [35].  Moreover, if lesioned rats exhibited an 



































































enhancement and/or motor impairments at lower doses of haloperidol than would 
sham-operated rats (as was observed with SCH23390).  Because we did not 
observe enhanced sensitivity haloperidol following medial PFC lesions, we 
speculate that D2 receptors were unaltered by the lesion and thereby did not 
contribute to the decision-making deficit observed in the current experiment. 
 
We were surprised by the lack of effect of haloperidol on decision-making in the 
current experiment because the D2 receptor antagonist eticlopride has been 
found to improve decision-making in both the rodent gambling task [15] and a 
probabilistic reinforcement task [32].  The discrepancy in the effects of eticlopride 
and haloperidol may lie in their affinities for different D2-like receptor subtypes; 
eticlopride is much more selective for the D2 receptor than is haloperidol [36].  
Indeed, haloperidol has affinity for D3 and D4 receptors in addition to D2 
receptors [37], while eticlopride has marginal affinity for these receptors [36].  In 
another decision-making task the effect of D3 receptor stimulation was opposite 
that of D2 receptor stimulation [32].  Thus, haloperidol may not affect decision-
making in this task because it binds to both D2 and D3 receptors; these receptors 
appear to have opposite effects on decision-making.     
 
4.4 Summary and Conclusions 
In summary, we observed that excitotoxic lesions of the medial PFC caused 
impairments in decision-making in rats that displayed a stable pattern of optimal 
decision-making prior to undergoing surgery.  Moreover, it is likely that the impairment 
in decision-making was mediated, at least in part, by increased sensitivity or 
upregulation of dopamine D1 receptors; the D1-like receptor antagonist SCH23390 
restored optimal decision-making in lesioned rats.  Consistent with previous findings 
SCH23390 did not affect decision-making in sham-operated control rats.  The D2-like 
receptor antagonist haloperidol did not affect decision-making in either sham-operated 




































































These data suggest that the deficits in medial PFC function and concomitant changes in 
dopamine signaling may be contributing to the decision-making deficits observed in a 
number of psychiatric illnesses.  Indeed, schizophrenia [38], ADHD [2], substance 
abuse [3], and Parkinson‘s Diseases [5] have all be associated with abnormalities in 
cortical functioning and dopamine signaling.  Thus, treatments that address these 
pathologies may help to normalize the suboptimal decision-making strategies seen 
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Figure 1.  The location and extent of ibotenic acid lesions of the medial prefrontal cortex 
(PFC).  A) Schematic showing the largest (grey) and smallest (black) extent of the 
lesion on any particular section through the medial PFC.  B) Photomicrograph depicting 
the average extent of damage caused by ibotenic acid infusions.  Adapted from [24]. 
 
Figure 2.  Effects of medial PFC lesions on performance in the rodent gambling task.  
A) % Advantageous responses.  Lesioned rats exhibit a decrease in their choice of 
advantageous options that progressively worsened across testing.  B) % Choice of each 
hole (H).  All rats chose hole 2 (most optimal) more than they chose the other 3 options.  
Lesioned rats chose hole 3 more frequently than sham-operated rats on post-lesion 
days 1, 4 and 5 and chose hole 1 less frequently than sham-operated rats on post-
lesion day 3.  There was no effects of either condition or day of testing on the  % 
Omissions (C), the % Premature responses (D), or the number of magazine entries 
made (E).  *P < 0.05 sham-operated vs lesion; #P < 0.05 lesion compared to baseline; 
^P < 0.05 both groups compared to baseline;  ‡P < 0.5, sham-operated vs lesion hole 1; 
†P < 0.05 sham-operated vs lesion hole 3; ∞P < 0.05 hole 2 vs all other holes. 
 
Figure 3.  Effects of SCH23390 on choice behavior in the rodent gambling task.  A) 
Lesioned rats chose the advantageous holes less frequently than sham-operated rats; 
this effect was attenuated by SCH23390 administration.  B) All rats chose hole 2 more 
frequently than all other holes.  In addition sham-operated rats chose hole 2 more 
frequently than lesioned rats.  SCH23390 did not affect hole choice.  C) SCH23390 
increased the % omissions in lesioned, but not sham-operated, rats.  D) SCH23390 
administration significantly decreased the % premature responding; this effect was 
potentiated in lesioned rats.  E) SCH23390 administration significantly reduced the 
number of magazine entries. *P < 0.05 sham-operated vs lesion; #P < 0.05 lesion 
compared to baseline; ^P < 0.05 both groups compared to baseline; ∞P < 0.05 hole 2 vs 




































































Figure 4.  Effects of haloperidol on choice behavior in the rodent gambling task.  A) 
Lesioned rats chose the advantageous holes less frequently than sham-operated rats; 
this effect was not affected by haloperidol administration.  B) All rats chose hole 2 more 
than all other holes. In addition sham-operated rats chose hole 2 more frequently and 
chose hole 3 less frequently than lesioned rats.  Haloperidol did not affect hole choice.  
C) Haloperidol did not affect % omissions.  D) Haloperidol (0.03 mg/kg) increased the % 
premature responding.  E) There was a tendency for lesioned rats to make more 
magazine entries than sham-operated rats; this was not affected by haloperidol 
administration. *P < 0.05 sham-operated vs lesion; #P < 0.05 lesion compared to 
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Table 1.  Example of response contingencies across nose poke holes 
 Hole (H) 1 H2 H3 H4 
# of Rewards 4 1 3 2 
Punishment 
Duration (sec) 
40 5 30 10 
Probability of 
Punishment 
0.6 0.1 0.5 0.2 
Note: There were 4 different spatial arrangements of outcomes; one such arrangement 
is depicted here.  An individual rat was assigned a single arrangement for the duration 
of the experiment.  On rewarded trials the number of pellets indicated were delivered for 
that choice; on punished trials the no pellets were delivered.  
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